ABT Abbott Laboratories Earnings and EPS analysis

EPS in 2026 (TTM): $3.1

Last Report Period Date: Jun 30, 2026

As of August this year, based on Abbott Laboratories's most recent financial report, the company's trailing twelve months EPS is $3.1. Abbott Laboratories's earnings per share in 2025 was reported at $3.73, marking a decline from $7.67 in 2024. Abbott Laboratories's EPS for the quarterly period ending on Jun 30, 2026 came in at $0.53.

The yearly earnings per share during 2025 was $3.73, a decline of 51.4% compared to $7.67 recorded in 2024. The quarterly earnings per share for the period ending Jun 30, 2026, was $0.53, showing a 48% decline compared to the same quarter last year. The trailing twelve months EPS for ABT is $3.1 as of June 2026. Abbott Laboratories's full-year EPS for 2024 was $7.67, a 133.8% rise compared to the previous year.

In the past 12 months, Abbott Laboratories has recorded an earnings per share growth rate of -48% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of -1.8% per year. In the last five years, the company had an average annual EPS growth of 8.2%. When assessed over a ten-year period, ABT's average EPS annual growth was 2.4%.